🇺🇸 FDA
Patent

US 12296050

Pharmaceutical compositions comprising maralixibat and uses thereof

granted A61KA61K31/4995A61K47/10

Quick answer

US patent 12296050 (Pharmaceutical compositions comprising maralixibat and uses thereof) held by MIRUM PHARMACEUTICALS, INC. expires Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
MIRUM PHARMACEUTICALS, INC.
Grant date
Tue May 13 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon May 08 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61K, A61K31/4995, A61K47/10, A61K47/12, A61K47/183